Condition: Breast Cancer · HER2-positive Breast Cancer · Triple Negative Breast Cancer · Sponsor: Brigham and Women's Hospital
This research study is studying the usefulness of magnetic resonance imaging (MRI) to screen for brain metastases (spread of the breast cancer to the brain).
This description comes directly from the study's public registry record.
Ayal Aizer, MD, MHS · 617-732-7560 · aaaizer@partners.org
Ivy Ricca, BA · 6175828927 · iricca@mgb.org
Always discuss trial participation with your own doctor first.
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04030507